etoposide injection
hikma pharmaceuticals usa inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - etoposide injection, usp is indicated in the management of the following neoplasms: etoposide injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.
etoposide 20mg/ml concentrate for solution for infusion concentrate for solution for infusion
accord healthcare limited - etoposide - concentrate for solution for infusion - 20mg/ml
vepesid 100 mg capsule, soft
bristol-myers squibb pharmaceuticals uc - etoposide - capsule, soft - 100 milligram(s) - podophyllotoxin derivatives; etoposide
vepesid 50 mg capsule, soft
bristol-myers squibb pharmaceuticals uc - etoposide - capsule - 50 mg milligram(s) - podophyllotoxin derivatives; etoposide
etoposide 20mg/ml concentrate for solution for infusion (200mg/10ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide 20mg/ml concentrate for solution for infusion (250mg/12.5ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide 20mg/ml concentrate for solution for infusion (400mg/20ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide 20mg/ml concentrate for solution for infusion (500mg/25ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide 20mg/ml concentrate for solution for infusion (1000mg/50ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide ebewe etoposide 100mg/5ml injection vial
sandoz pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: ethanol; citric acid; polysorbate 80; macrogol 300; benzyl alcohol - small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia; hodgkin's disease non-hodgkin's lymphoma.